Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 248.67 Million INR | 7.44% |
| 2022 | 231.46 Million INR | -55.64% |
| 2021 | 521.84 Million INR | -16.08% |
| 2020 | 621.81 Million INR | 16.96% |
| 2019 | 531.66 Million INR | 111.72% |
| 2018 | 251.11 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 288 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 248.67 Million INR | 7.44% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 248.67 Million INR | 0.0% |
| 2022 Q4 | 231.46 Million INR | -36.77% |
| 2022 FY | 231.46 Million INR | -55.64% |
| 2022 Q3 | 366.06 Million INR | 0.0% |
| 2021 Q4 | 521.84 Million INR | 0.0% |
| 2021 FY | 521.84 Million INR | -16.08% |
| 2020 FY | 621.81 Million INR | 16.96% |
| 2019 FY | 531.66 Million INR | 111.72% |
| 2018 FY | 251.11 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 60.452% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 98.835% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -68.469% |
| Granules India Limited | 689.71 Million INR | 63.945% |
| Indoco Remedies Limited | 3.51 Billion INR | 92.93% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 235.2 Million INR | -5.73% |
| Alkem Laboratories Limited | 400 Million INR | 37.831% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -6875.512% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -793.365% |
| Bajaj HealthCare Limited | 650.34 Million INR | 61.762% |
| Bliss GVS Pharma Limited | 355.92 Million INR | 30.132% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 95.848% |
| Eris Lifesciences Limited | 6.54 Billion INR | 96.201% |
| FDC Limited | 2.46 Million INR | -9984.225% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 83.606% |
| Gufic Biosciences Limited | 1.53 Billion INR | 83.848% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -122.777% |
| Ipca Laboratories Limited | 5.8 Billion INR | 95.715% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -229.068% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 86.448% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 97.11% |
| Lupin Limited | 1.55 Billion INR | 83.985% |
| Medicamen Biotech Limited | 12.55 Million INR | -1880.701% |
| Medico Remedies Limited | 8.67 Million INR | -2767.585% |
| Megasoft Limited | 1.35 Billion INR | 81.675% |
| NATCO Pharma Limited | 53 Million INR | -369.202% |
| Piramal Pharma Limited | 24.83 Billion INR | 98.999% |
| RPG Life Sciences Limited | -30.3 Million INR | 920.716% |
| Sigachi Industries Limited | 265.79 Million INR | 6.441% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -1769.752% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -17.104% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 20500.082% |
| Unichem Laboratories Limited | 382.22 Million INR | 34.939% |
| Wanbury Limited | 820 Million INR | 69.674% |
| Windlas Biotech Limited | 20.18 Million INR | -1132.294% |
| ZIM Laboratories Limited | 356 Million INR | 30.148% |
| Zydus Lifesciences Limited | 251 Million INR | 0.925% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -133.28% |
| Divi's Laboratories Limited | 20 Million INR | -1143.385% |
| Hester Biosciences Limited | 1.81 Billion INR | 86.319% |
| Procter & Gamble Health Limited | 68.8 Million INR | -261.449% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -1680.334% |
| Bal Pharma Limited | 363.82 Million INR | 31.649% |
| Strides Pharma Science Limited | 6.71 Billion INR | 96.297% |
| Venus Remedies Limited | 386.8 Million INR | 35.709% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -62069.25% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 82.276% |
| Shilpa Medicare Limited | 5.6 Billion INR | 95.561% |
| Aarti Drugs Limited | 2.75 Billion INR | 90.968% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 97.537% |
| Valiant Laboratories Limited | 746.63 Million INR | 66.693% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -5.193% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 76.502% |
| Themis Medicare Limited | 267.74 Million INR | 7.12% |
| Hikal Limited | 4.22 Billion INR | 94.119% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 98.45% |
| Sequent Scientific Limited | 1.42 Billion INR | 82.576% |
| Novartis India Limited | 50.7 Million INR | -390.487% |
| Wockhardt Limited | 8.91 Billion INR | 97.209% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 99.215% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Neuland Laboratories Limited | 449.2 Million INR | 44.641% |
| Morepen Laboratories Limited | 33.64 Million INR | -639.23% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -86.218% |